Status:
RECRUITING
Zero-cost Radiation Protection Method to Reduce Radiation Exposure of Interventional Cardiologists During Transradial Percutaneous Coronary Procedures (FREEPADRAD Trial)
Lead Sponsor:
National and Kapodistrian University of Athens
Conditions:
Occupational Radiation Exposure in Interventional Cardiology
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Ionising radiation is a recognised occupational hazard in interventional cardiology. This prospective, randomised trial aims to evaluate the effectiveness of additional radiation protection by existin...
Detailed Description
Ionizing radiation refers to any type of radiation capable of interacting with matter. It plays a vital role in medical diagnostics and therapeutic applications. Imaging techniques allow for timely an...
Eligibility Criteria
Inclusion
- Patients undergoing transradial diagnostic coronary angiography or angioplasty.
- Adults aged 18 years and older.
- Informed consent provided.
Exclusion
- Acute STEMI requiring primary percutaneous coronary intervention (PCI).
- Patients undergoing structural heart interventions.
- Initially femoral access or crossover to femoral access procedures.
- Patients unable to provide informed consent.
Key Trial Info
Start Date :
January 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06931171
Start Date
January 30 2025
End Date
December 31 2025
Last Update
April 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
First Department of Cardiology, Hippokration General Hospital of Athens
Athens, Attica, Greece, 11527
2
First Department of Cardiology, National and Kapodistrian University of Athens, Hippokration General Hospital of Athens
Athens, Attica, Greece, 11527